Literature DB >> 21940628

Mutually opposite signal modulation by hypothalamic heterodimerization of ghrelin and melanocortin-3 receptors.

Anne Rediger1, Carolin L Piechowski, Chun-Xia Yi, Patrick Tarnow, Rainer Strotmann, Annette Grüters, Heiko Krude, Torsten Schöneberg, Matthias H Tschöp, Gunnar Kleinau, Heike Biebermann.   

Abstract

Interaction and cross-talk of G-protein-coupled receptors (GPCRs) are of considerable interest because an increasing number of examples implicate a profound functional and physiological relevance of homo- or hetero-oligomeric GPCRs. The ghrelin (growth hormone secretagogue receptor (GHSR)) and melanocortin-3 (MC3R) receptors are both known to have orexigenic effects on the hypothalamic control of body weight. Because in vitro studies indicate heterodimerization of GHSR and MC3R, we investigated their functional interplay. Combined in situ hybridization and immunohistochemistry indicated that the vast majority of GHSR-expressing neurons in the arcuate nucleus also express MC3R. In vitro coexpression of MC3R and GHSR promoted enhanced melanocortin-induced intracellular cAMP accumulation compared with activation of MC3R in the absence of GHSR. In contrast, agonist-independent basal signaling activity and ghrelin-induced signaling of GHSR were impaired, most likely due to interaction with MC3R. By taking advantage of naturally occurring GHSR mutations and an inverse agonist for GHSR, we demonstrate that the observed enhanced MC3R signaling capability depends directly on the basal activity of GHSR. In conclusion, we demonstrate a paradigm-shifting example of GPCR heterodimerization allowing for mutually opposite functional influence of two hypothalamic receptors controlling body weight. We found that the agonist-independent active conformation of one GPCR can determine the signaling modalities of another receptor in a heterodimer. Our discovery also implies that mutations within one of two interacting receptors might affect both receptors and different pathways simultaneously. These findings uncover mechanisms of important relevance for pharmacological targeting of GPCR in general and hypothalamic body weight regulation in particular.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21940628      PMCID: PMC3234785          DOI: 10.1074/jbc.M111.287607

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

Review 1.  Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.

Authors:  Kurt Kristiansen
Journal:  Pharmacol Ther       Date:  2004-07       Impact factor: 12.310

Review 2.  Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation.

Authors:  Birgitte Holst; Thue W Schwartz
Journal:  Trends Pharmacol Sci       Date:  2004-03       Impact factor: 14.819

Review 3.  Isoforms of mammalian adenylyl cyclase: multiplicities of signaling.

Authors:  Roger K Sunahara; Ron Taussig
Journal:  Mol Interv       Date:  2002-06

4.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

5.  From molecular details of the interplay between transmembrane helices of the thyrotropin receptor to general aspects of signal transduction in family a G-protein-coupled receptors (GPCRs).

Authors:  Gunnar Kleinau; Inna Hoyer; Annika Kreuchwig; Ann-Karin Haas; Claudia Rutz; Jens Furkert; Catherine L Worth; Gerd Krause; Ralf Schülein
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

6.  Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans.

Authors:  Supriya Srinivasan; Cecile Lubrano-Berthelier; Cedric Govaerts; Franck Picard; Pamela Santiago; Bruce R Conklin; Christian Vaisse
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

7.  Inactivation and intracellular retention of the human I183N mutated melanocortin 3 receptor associated with obesity.

Authors:  Mohamed Rached; Anna Buronfosse; Martine Begeot; Armelle Penhoat
Journal:  Biochim Biophys Acta       Date:  2004-08-04

8.  A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells.

Authors:  H Okayama; P Berg
Journal:  Mol Cell Biol       Date:  1983-02       Impact factor: 4.272

9.  High constitutive signaling of the ghrelin receptor--identification of a potent inverse agonist.

Authors:  Birgitte Holst; Adam Cygankiewicz; Tine Halkjaer Jensen; Michael Ankersen; Thue W Schwartz
Journal:  Mol Endocrinol       Date:  2003-08-07

10.  Functional characterization of melanocortin-3 receptor variants identify a loss-of-function mutation involving an amino acid critical for G protein-coupled receptor activation.

Authors:  Ya-Xiong Tao; Deborah L Segaloff
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

View more
  44 in total

1.  Orexin A/Hypocretin Modulates Leptin Receptor-Mediated Signaling by Allosteric Modulations Mediated by the Ghrelin GHS-R1A Receptor in Hypothalamic Neurons.

Authors:  Mireia Medrano; David Aguinaga; Irene Reyes-Resina; Enric I Canela; Josefa Mallol; Gemma Navarro; Rafael Franco
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

Review 2.  Olfaction under metabolic influences.

Authors:  Brigitte Palouzier-Paulignan; Marie-Christine Lacroix; Pascaline Aimé; Christine Baly; Monique Caillol; Patrice Congar; A Karyn Julliard; Kristal Tucker; Debra Ann Fadool
Journal:  Chem Senses       Date:  2012-07-25       Impact factor: 3.160

3.  Structure-activity relationships of peptides incorporating a bioactive reverse-turn heterocycle at the melanocortin receptors: identification of a 5800-fold mouse melanocortin-3 receptor (mMC3R) selective antagonist/partial agonist versus the mouse melanocortin-4 receptor (mMC4R).

Authors:  Anamika Singh; Marvin Dirain; Rachel Witek; James R Rocca; Arthur S Edison; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2013-03-25       Impact factor: 7.446

Review 4.  Orphan neuropeptides and receptors: Novel therapeutic targets.

Authors:  Lloyd D Fricker; Lakshmi A Devi
Journal:  Pharmacol Ther       Date:  2017-11-22       Impact factor: 12.310

5.  Promiscuous dimerization of the growth hormone secretagogue receptor (GHS-R1a) attenuates ghrelin-mediated signaling.

Authors:  Harriët Schellekens; Wesley E P A van Oeffelen; Timothy G Dinan; John F Cryan
Journal:  J Biol Chem       Date:  2012-11-16       Impact factor: 5.157

6.  Hyperactive hypothalamus, motivated and non-distractible chronic overeating in ADAR2 transgenic mice.

Authors:  A Akubuiro; M Bridget Zimmerman; L L Boles Ponto; S A Walsh; J Sunderland; L McCormick; M Singh
Journal:  Genes Brain Behav       Date:  2013-02-18       Impact factor: 3.449

Review 7.  Melanocortin-3 receptors and metabolic homeostasis.

Authors:  Karima Begriche; Clemencé Girardet; Patricia McDonald; Andrew A Butler
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

Review 8.  Neural melanocortin receptors in obesity and related metabolic disorders.

Authors:  Clemence Girardet; Andrew A Butler
Journal:  Biochim Biophys Acta       Date:  2013-05-13

9.  α₁A-adrenergic receptors regulate cardiac hypertrophy in vivo through interleukin-6 secretion.

Authors:  Robert S Papay; Ting Shi; Michael T Piascik; Sathyamangla V Naga Prasad; Dianne M Perez
Journal:  Mol Pharmacol       Date:  2013-02-12       Impact factor: 4.436

10.  Assessing interactions between Ghsr and Mc3r reveals a role for AgRP in the expression of food anticipatory activity in male mice.

Authors:  Clemence Girardet; Maria Mavrikaki; Mark R Southern; Roy G Smith; Andrew A Butler
Journal:  Endocrinology       Date:  2014-09-11       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.